Lasmiditan, a First-In-Class Migraine Treatment, Now Available
This first-in-class, serotonin (5-HT) 1F receptor agonist is believed to exert its therapeutic effects both centrally and peripherally.
All articles by Brian Park, PharmD
Potential Presence of Foreign Substance Prompts Recall of Alprazolam Lot
Mylan Pharmaceuticals announced the voluntary recall of one lot of alprazolam 0.5mg tablets to the consumer/user level due to the potential presence of a foreign substance.
Next post in Neurobehavioral Disorders
